STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
History
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
FY Mar 2021
n/a
FY Mar 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
History
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
FY Mar 2021
n/a
FY Mar 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
History
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
FY Mar 2021
n/a
FY Mar 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
History
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
FY Mar 2021
n/a
FY Mar 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
History
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
FY Mar 2021
n/a
FY Mar 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
no equity line filed
History
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
FY Mar 2021
n/a
FY Mar 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-49.0%
TTM net income over average of 2023-12-31 and 2024-12-31
History
FY Mar 2024
-33.7%
FY Mar 2023
n/a
FY Mar 2022
n/a
FY Mar 2021
n/a
FY Mar 2020
n/a
Dec 2024
-49.0%
Sep 2024
-54.3%
Jun 2024
-48.1%
Mar 2024
-33.7%
Dec 2023
-31.0%
Sep 2023
-25.3%
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
History
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
FY Mar 2021
n/a
FY Mar 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
History
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
FY Mar 2021
n/a
FY Mar 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
History
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
FY Mar 2021
n/a
FY Mar 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no close on file at or before the as-of date
History
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
FY Mar 2021
n/a
FY Mar 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no close on file at or before the as-of date
History
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
FY Mar 2021
n/a
FY Mar 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
History
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
FY Mar 2021
n/a
FY Mar 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of none on file. Hover a figure to see how it was computed.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Short interest, % of float+1.8% · 78 pct, sector of 92
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
6 not measured: Profitability, Financial health, Growth, Insider conviction, Institutional and government, US patents
Profitability needs 2 of 4 inputs, 1 present: fewer than four consecutive quarters of operating income; no equity line filed
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Insider conviction needs 1 of 2 inputs, 0 present: no insider trades in 180 days; no open-market insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
1 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
What the filings say about GP
Members of Congress have disclosed trades in GP, none in the last year; the latest on record is a purchase by Scott H. Peters dated 2024-09-11. Each figure is counted from SEC and House filings as of 2026-10-12, dated the day the filing was made public.
GP filings FAQ
Have members of Congress traded GP?
Yes, but not in the year to 2026-10-12; the latest on record is a purchase by Scott H. Peters dated 2024-09-11.
No password to create and no card required. We store your email address and nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in. Google Analytics and
Microsoft Clarity load only if you allow them here, to show us which datasets matter.
No ad trackers, ever. Details in the privacy
policy.